TAK-070

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTAK-070
Drug Alias NameTAK-070
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-secretase 1 inhibitors
TargetsBeta-secretase 1
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A